The roles of dipeptidyl peptidase-4 inhibitors in prognosis of COVID-19 infection in patients with type 2 diabetes mellitus by Mohammad Sadidi, Ahad Zare, Mehrdad Nasrollahzadehsabet, Farzaneh Dastan, Ali Mosadegh Khah, Milad Jafari Asheyani

Subjects: Get full text

Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database by Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon Kim

Subjects: “…Dipeptidyl-peptidase IV inhibitors…”
Get full text

Factors associated with the glucose‐lowering efficacy of sitagliptin in Japanese patients with type 2 diabetes mellitus: Pooled analysis of Japanese clinical trials by Naoko Tajima, Jun‐ichi Eiki, Taro Okamoto, Kotoba Okuyama, Masaru Kawashima, Samuel S Engel

Subjects: “…Dipeptidyl peptidase‐4 inhibitors…”
Get full text

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin by Jong Ho Kim, Sang Soo Kim, Hong Sun Baek, In Kyu Lee, Dong Jin Chung, Ho Sang Sohn, Hak Yeon Bae, Mi Kyung Kim, Jeong Hyun Park, Young Sik Choi, Young Il Kim, Jong Ryeal Hahm, Chang Won Lee, Sung Rae Jo, Mi Kyung Park, Kwang Jae Lee, In Joo Kim

Subjects: “…Dipeptidyl peptidase 4 inhibitor…”
Get full text

Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature by Yosuke Mai, Wataru Nishie, Kazumasa Sato, Moeko Hotta, Kentaro Izumi, Kei Ito, Kazuyoshi Hosokawa, Hiroshi Shimizu

Subjects: Get full text

Acute pancreatitis with gliptins: Is it a clinical reality? by Muthukrishnan Jayaraman, Sandeep Kumar, Atul Kumar Sood

Subjects: “…Dipeptidyl peptidase-4 inhibitors…”
Get full text

Effects of metformin and alogliptin on body composition in people with type 2 diabetes by Yumie Takeshita, Yuki Kita, Ken‐ichiro Kato, Takehiro Kanamori, Hirofumi Misu, Shuichi Kaneko, Toshinari Takamura

Subjects: “…Dipeptidyl peptidase‐4 inhibitors…”
Get full text

Inhibition of dipeptidyl peptidase IV (DPP-IV) by proline containing casein-derived peptides by Alice B. Nongonierma, Richard J. FitzGerald

Subjects: “…Dipeptidyl peptidase IV inhibitors…”
Get full text

Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blin... by Linong Ji, Ling Li, Jianhua Ma, Xuefeng Li, Dongmei Li, Bangzhu Meng, Weiping Lu, Jiao Sun, Yanmei Liu, Gen Takayanagi, Yi Wang

Subjects: Get full text

Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis by Mee Kyoung Kim, Kyungdo Han, Hyuk-Sang Kwon, Soon Jib Yoo

Subjects: Get full text

Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors by Sangmo Hong, Chang Hee Jung, Song Han, Cheol-Young Park

Subjects: Get full text

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180 by Yosuke Mai, Wataru Nishie, Kentaro Izumi, Hiroshi Shimizu

Subjects: Get full text

The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study by Vaia Lambadiari, Aikaterini Kountouri, Foteini Kousathana, Emmanouil Korakas, Georgios Kokkalis, Sofia Theotokoglou, Lina Palaiodimou, Pelagia Katsimbri, Ignatios Ikonomidis, Konstantinos Theodoropoulos, Evangelia Papadavid

Subjects: Get full text

Teneligliptin in Early Diabetic Kidney Disease: An Observation in Asian Indian Patients with Type 2 Diabetes Mellitus in Real-Life Scenario by Kiran Shah

Subjects: Get full text

Teneligliptin in Management of Diabetic Kidney Disease: A Review of Place in Therapy by Mohammed Abubaker, Preetesh Mishra, Onkar C. Swami

Subjects: Get full text

Association of dipeptidyl peptidase‐4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan by Sodai Kubota, Takuya Haraguchi, Hitoshi Kuwata, Yusuke Seino, Kenta Murotani, Takumi Tajima, Gen Terashima, Makiko Kaneko, Yoshihiro Takahashi, Ken Takao, Takehiro Kato, Kenichiro Shide, Saeko Imai, Atsushi Suzuki, Yasuo Terauchi, Yuichiro Yamada, Yutaka Seino, Daisuke Yabe

Subjects: Get full text

Dynamics of total volume of pancreatic α‐ and β ‐cells under the influence sulfonylureas and their combination with dipeptidyl peptidase‐4 inhibitors by Tuchina Taisiia Pavlovna, Skotnikova Kseniia Petrovna, Vtorushina Anna Anatolievna, Uskov Ivan Sergeyevich, Rogoza Olga Vladimirovna, Grozov Roman Viktorovich, Babenko Alina Yurievna, Galagudza Mikhail Mikhailovich

Subjects: “…dipeptidyl peptidase‐4 inhibitors…”
Get full text

Vildagliptin: the first innovative DDP-4 inhibitor by Edvin Villkhauer

Subjects: “…dipeptidyl peptidase-4 inhibitor…”
Get full text

Time to exacerbation of heart failure is longer in Malaysian population on dipeptidyl peptidase-4 inhibitor by J Hasan, R Najme Khir, M A Saman, K S Ibrahim, J R Ismail, R A Ghani, C W Lim, Z Ibrahim, E A Rahman, N Chua, HAZ Abidin, MKM Arshad, S Kasim

Subjects: Get full text

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insuffici... by Hiroshi Takahashi, Rimei Nishimura, Daisuke Tsujino, Kazunori Utsunomiya

Subjects: Get full text